Get started
WuXi Biologics (Cayman) Inc. Unsponsored ADRWuXi Biologics (Cayman) Inc. Unsponsored ADRWuXi Biologics (Cayman) Inc. Unsponsored ADR

WuXi Biologics (Cayman) Inc. Unsponsored ADR

No trades
See on Supercharts
Overview
Financials News Discussions Forecast

A2PQ3Q chart


Full chart

A2PQ3Q upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪16.55 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
34.4453
Basic EPS (TTM)
0.2430 EUR
Net income (FY)
‪450.46 M‬ EUR
Revenue (FY)
‪2.51 B‬ EUR
Shares float
—
Beta (1Y)
0.71

About Wuxi Biologics (Cayman) Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Zhi Sheng Chen
Website
wuxibiologics.com
Headquarters
Wuxi
Founded
2014
ISIN
US98260N1081
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.

Check out other big names from the same industry as A2PQ3Q.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

A2PQ3Q news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy